Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts

Oncogene volume 22, pages 4993–5005 (2003)Cite this article

Abstract

p19ARF is induced in response to oncogene activation or during cellular senescence in mouse embryo fibroblasts, triggering p53-dependent and p53-independent cell cycle arrest and apoptosis. We have studied the involvement of human p14ARF as a regulator of p53 activity in normal human skin fibroblasts (NHFs) or WI38 lung embryonic fibroblasts expressing conditional Myc or E2F1 estrogen receptor fusion proteins. Both Myc and E2F1 activation rapidly induced p53 phosphorylation at Ser-15, p53 protein accumulation, and upregulation of the p53 target genes MDM2 and p21. Activation of E2F1 induced p14ARF mRNA and protein levels. In contrast, Myc activation did not induce any significant increase in p14ARF mRNA or protein levels in neither NHFs nor WI38 fibroblasts within 48 h. Myc and E2F1 induced p53 and cell cycle arrest even after silencing of p14ARF using short-interfering RNA. Treatment with the ATM/ATR kinase inhibitor caffeine prevented p53 accumulation upon activation of Myc or E2F1. Our results indicate that p53 phosphorylation, but not p14ARF, plays a major role for the induction of p53 in response to Myc and E2F1 activation in normal human fibroblasts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Abraham RT . (2001). Genes Dev., 15, 2177–2196.

  • Alarcon-Vargas D and Ronai Z . (2002). Carcinogenesis, 23, 541–547.

  • Askew DS, Ashmun RA, Simmonds BC and Cleveland JL . (1991). Oncogene, 6, 1915–1922.

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH . (1998). Nature, 395, 124–125.

  • Bakkenist CJ and Kastan MB . (2003). Nature, 421, 499–506.

  • Berkovic E and Ginsberg D . (2003). Oncogene, 22, 161–167.

  • Blasina A, Price BD, Turenne GA and McGowan CH . (1999). Curr. Biol., 9, 1135–1138.

  • Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W and Peters G . (2002). EMBO J., 21, 2936–2945.

  • Chehab NH, Malikzay A, Stavridi ES and Halazonetis TD . (1999). Proc. Natl. Acad. Sci. USA, 96, 13777–13782.

  • Chen QM, Liu J and Merrett JB . (2000). Biochem. J., 347, 543–551.

  • Cole MD and McMahon SB . (1999). Oncogene, 18, 2916–2924.

  • Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR . (2000). Proc. Natl. Acad. Sci. USA, 97, 3260–3265.

  • Colombo E, Marine JC, Danovi D, Falini B and Pelicci PG . (2002). Nat. Cell Biol., 4, 529–533.

  • Cong F, Zou X, Hinrichs K, Calame K and Goff SP . (1999). Oncogene, 18, 7731–7739.

  • Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A and Oren M . (2001). EMBO J., 20, 4912–4922.

  • Deplanque G, Vincent F, Mah-Behcherel MCM, Cazenave J-P, Bergerat J-P and Klein-Soyer C . (2000). Br. J. Cancer, 83, 346–353.

  • de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW . (1998). Genes Dev., 12, 2434–2442.

  • Devasagayam TP, Kamat JP, Mohan H and Kesavan PC . (1996). Biochim. Biophys. Acta, 1282, 63–70.

  • Dimri GP, Itahana K, Acosta M and Campisi J . (2000). Mol. Cell. Biol., 20, 273–285.

  • Drayton S and Peters G . (2002). Curr. Opin. Genet. Dev., 12, 98–104.

  • Eilers M, Picard D, Yamamoto KR and Bishop JM . (1989). Nature, 340, 66–68.

  • Eischen CM, Weber JD, Roussel MF, Sherr CJ and Cleveland JL . (1999). Genes Dev., 13, 2658–2669.

  • Eisenman RN . (2001). Genes Dev., 15, 2023–2030.

  • el-Deiry WS . (1998). Semin. Cancer Biol., 8, 345–357.

  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC . (1992). Cell, 69, 119–128.

  • Felsher DW and Bishop JM . (1999). Proc. Natl. Acad. Sci. USA, 96, 3940–3944.

  • Felsher DW, Zetterberg A, Zhu J, Tlsty T and Bishop JM . (2000). Proc. Natl. Acad. Sci. USA, 97, 10544–10548.

  • Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C and Lowe SW . (2000). Genes Dev., 14, 2015–2027.

  • Gomez-Roman N, Grandori C, Eisenman RN and White RJ . (2003). Nature, 421, 290–294.

  • Hall-Jackson CA, Cross DA, Morrice N and Smythe C . (1999). Oncogene, 18, 6707–6713.

  • Hashemi J, Lindström MS, Asker C, Platz A, Hansson J and Wiman KG . (2002). Cancer Lett., 180, 211–221.

  • Henriksson M, Selivanova G, Lindström MS and Wiman KG . (2001). Apoptosis, 6, 133–137.

  • Hermeking H and Eick D . (1994). Science, 265, 2091–2093.

  • Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B and Kinzler KW . (2000). Proc. Natl. Acad. Sci. USA, 97, 2229–2234.

  • Hirst SK and Grandori C . (2000). Oncogene, 19, 5189–5197.

  • Honda R and Yasuda H . (1999). EMBO J., 18, 22–27.

  • Huot TJ, Rowe J, Harland M, Drayton S, Brookes S, Gooptu C, Purkis P, Fried M, Bataille V, Hara E, Newton-Bishop J and Peters G . (2002). Mol. Cell. Biol., 22, 8135–8143.

  • Inoue K, Roussel MF and Sherr CJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 3993–3998.

  • Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day 3rd RS, Johnson BE and Skolnick MH . (1994). Science, 264, 436–440.

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ . (1997). Cell, 91, 649–659.

  • Korgaonkar C, Zhao L, Modestou M and Quelle DE . (2002). Mol. Cell. Biol., 22, 196–206.

  • Kowalik TF, DeGregori J, Schwarz JK and Nevins JR . (1995). J. Virol., 69, 2491–2500.

  • Krimpenfort P, Quon KC, Mooi WJ, Loonstra A and Berns A . (2001). Nature, 413, 83–86.

  • Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ and Roussel MF . (2003). Cancer Res., 63, 1046–1053.

  • Lee C . (2000). Clin. Chim. Acta, 295, 141–154.

  • Li Q and Dang CV . (1999). Mol. Cell. Biol., 19, 5339–5351.

  • Lindström MS, Klangby U, Inoue R, Pisa P, Wiman KG and Asker CE . (2000). Exp. Cell. Res., 256, 400–410.

  • Lindström MS, Klangby U and Wiman KG . (2001). Oncogene, 20, 2171–2177.

  • Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI . (1995). Nucleic Acids Res., 23, 1686–1690.

  • Llanos S, Clark PA, Rowe J and Peters G . (2001). Nat. Cell Biol., 3, 445–452.

  • Lomazzi M, Moroni MC, Jensen MR, Frittoli E and Helin K . (2002). Nat. Genet., 31, 190–194.

  • Minella AC, Swanger J, Bryant E, Welcker M, Hwang H and Clurman BE . (2002). Curr. Biol., 12, 1817–1827.

  • Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H and Helin K . (2001). Nat. Cell Biol., 3, 552–558.

  • Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and Helin K . (2001). Genes Dev., 15, 267–285.

  • Muller H and Helin K . (2000). Biochim. Biophys. Acta, 1470, M1–M12.

  • Nahle Z, Polakoff J, Davuluri RV, McCurrach ME, Jacobson MD, Narita M, Zhang MQ, Lazebnik Y, Bar-Sagi D and Lowe SW . (2002). Nat. Cell Biol., 4, 859–864.

  • Palmero I, Murga M, Zubiaga A and Serrano M . (2002). Oncogene, 21, 2939–2947.

  • Palmero I, Pantoja C and Serrano M . (1998). Nature, 395, 125–126.

  • Parisi T, Pollice A, Di Cristofano A, Calabro V and La Mantia G . (2002). Biochem. Biophys. Res. Commun., 291, 1138–1145.

  • Prives C . (1998). Cell, 95, 5–8.

  • Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F . (2000). Cell, 103, 321–330.

  • Robertson KD and Jones PA . (1998). Mol. Cell. Biol., 18, 6457–6473.

  • Rogoff HA, Pickering MT, Debatis ME, Jones S and Kowalik TF . (2002). Mol. Cell. Biol., 22, 5308–5318.

  • Ruggero D and Pandolfi PP . (2003). Nat. Rev. Cancer, 3, 179–192.

  • Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ and Johnson DG . (2002). Mol. Cell. Biol., 22, 1360–1368.

  • Santoni-Rugiu E, Falck J, Mailand N, Bartek J and Lukas J . (2000). Mol. Cell. Biol., 20, 3497–3509.

  • Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM and Abraham RT . (1999). Cancer Res., 59, 4375–4382.

  • Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE and Abraham RT . (1998). Cancer Res., 58, 4375–4382.

  • Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW and DePinho RA . (2001). Nature, 413, 86–91.

  • Sharpless NE and DePinho RA . (1999). Curr. Opin. Genet. Dev., 9, 22–30.

  • Sherr CJ . (1998). Genes Dev., 12, 2984–2991.

  • Sherr CJ and Weber JD . (2000). Curr. Opin. Genet. Dev., 10, 94–99.

  • Shieh SY, Ikeda M, Taya Y and Prives C . (1997). Cell, 91, 325–334.

  • Shiio Y, Donohoe S, Yi CE, Goodlett DR, Aebersold R and Eisenmann RN . (2002). EMBO J., 21, 5088–5096.

  • Stiewe T and Putzer BM . (2000). Nat. Genet., 26, 464–469.

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G . (1998). EMBO J., 17, 5001–5014.

  • Sugimoto MS, Kuo ML, Roussel MF and Sherr CJ . (2003). Mol. Cell, 11, 415–424.

  • Tanaka H, Matsumura I, Ezoe S, Satoh Y, Sakamaki T, Albanese C, Machii T, Pestell RG and Kanakura Y . (2002). Mol. Cell, 9, 1017–1029.

  • Tolbert D, Lu X, Yin C, Tantama M and Van Dyke T . (2002). Mol. Cell. Biol., 22, 370–377.

  • Tsai KY, MacPherson D, Rubinson DA, Crowley D and Jacks T . (2002). Curr. Biol., 12, 159–163.

  • Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM and Wahl GM . (2002). Mol. Cell, 9, 1031–1044.

  • Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC and Helin K . (1999). Mol. Cell. Biol., 19, 6379–6395.

  • Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.

  • Vousden KH . (2000). Cell, 103, 691–694.

  • Vousden KH . (2002). Biochim. Biophys. Acta, 1602, 47–59.

  • Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ and Zambetti GP . (2000). Genes Dev., 14, 2358–2365.

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ and Bar-Sagi D . (1999). Nat. Cell Biol., 1, 20–26.

  • Wei W, Hemmer RM and Sedivy JM . (2001). Mol. Cell. Biol., 21, 6748–6757.

  • Wei W and Sedivy JM . (1999). Exp. Cell Res., 253, 519–522.

  • Wu X and Levine AJ . (1994). Proc. Natl. Acad. Sci. USA, 91, 3602–3606.

  • Xirodimas D, Saville MK, Edling C, Lane DP and Lain S . (2001). Oncogene, 20, 4972–4983.

  • Zhang Y and Xiong Y . (1999). Mol. Cell, 3, 579–591.

  • Zhang Y and Xiong Y . (2001). Science, 292, 1910–1915.

  • Zhang Y, Xiong Y and Yarbrough WG . (1998). Cell, 92, 725–734.

  • Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R, Mattern MR, Winkler JD and Khanna KK . (2000). J. Biol. Chem., 275, 10342–10348.

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF . (1998). Genes Dev., 12, 2424–2433.

Download references

Acknowledgements

We are indebted to Drs Carla Grandori, Kristian Helin, Michael Bishop, Dean Felsher, and Anders Zetterberg for generously providing cells. This work was supported by the Swedish Cancer Society, the Cancer Society of Stockholm, Ingabritt och Arne Lundbergs Forskningsstiftelse (Gothenburg, Sweden), the Robert Lundberg foundation, and the Karolinska Institute.

Author information

Authors and Affiliations

  1. Department of Oncology-Pathology, Cancer Center Karolinska (CCK), R8:04, Karolinska Institutet, Stockholm, SE-171 76, Sweden

    Mikael S Lindström & Klas G Wiman

Authors
  1. Mikael S Lindström
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klas G Wiman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klas G Wiman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lindström, M., Wiman, K. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts. Oncogene 22, 4993–5005 (2003). https://doi.org/10.1038/sj.onc.1206659

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206659

Keywords

This article is cited by

Search

Advanced search

Quick links